Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium
Author(s) -
Mark van den Boogaard,
Arjen J. C. Slooter,
Roger J. M. Brüggemann,
Lisette Schoonhoven,
Albertus Beishuizen,
Wytze Vermeijden,
Danie Pretorius,
Jan de Koning,
Koen S. Simons,
Paul Dennesen,
Peter H. J. van der Voort,
Saskia Houterman,
Johannes G. van der Hoeven,
Peter Pickkers,
Margaretha C. E. van der Woude,
Anna Besselink,
Lieuwe S. Hofstra,
Peter E. Spronk,
Walter M. van den Bergh,
Dirk W. Donker,
Malaika Fuchs,
Attila Karakus,
Mirelle Koeman,
Mirella Van Duijnhoven,
Gerjon Hannink
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.0160
Subject(s) - medicine , delirium , haloperidol , placebo , intensive care unit , randomized controlled trial , psychomotor agitation , critically ill , intensive care , incidence (geometry) , anesthesia , mechanical ventilation , pediatrics , emergency medicine , intensive care medicine , physics , alternative medicine , pathology , optics , dopamine
Results of studies on use of prophylactic haloperidol in critically ill adults are inconclusive, especially in patients at high risk of delirium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom